The diagnosis and monitoring of systemic neurologic disease represents an ongoing and significant challenge. However, 21st century advances in ophthalmic imaging are opening up new opportunities for direct, instantaneous, in vivo, cost-effective, reiterative, noninvasive imaging of nerve morphology. Optical coherence tomography allows direct optical imaging of neural layers of the retina, and thinning of these layers has been shown to correlate with both ophthalmic and systemic diseases that involve nerve pathology. A technique that has been to some extent overshadowed by optical coherence tomography, in view of its perceived more limited utility in ophthalmic imaging, is corneal confocal microscopy. Proof of concept for assessing neurologic disease emerged from extensive research on the capability of this technique to diagnose, stage severity, monitor progression, and predict future incidence of diabetic peripheral neuropathy.
